2025“投资成都”全球招商大会举行 三大生物医药项目签约落地成都高新区

Core Insights - The "Investment in Chengdu" Global Investment Conference focused on the development of the biopharmaceutical industry park, attracting over 150 guests from various sectors to discuss high-quality development in the biopharmaceutical industry [1][7] - Three major projects were signed to establish a competitive biopharmaceutical ecosystem in Chengdu, specifically in high-end medical devices, biobreeding, and cell therapy [3][9] Group 1: Project Signings - Nine significant biopharmaceutical projects were signed during the conference, with three major projects located in Chengdu High-tech Zone, emphasizing their strategic importance in the biopharmaceutical industry [3][9] - Beijing Waterwood Medical plans to build a comprehensive service platform for innovative medical devices and CDMO in Chengdu High-tech Zone, aiming to create a one-stop service system covering design, testing, clinical trials, registration, and contract manufacturing [5][6] Group 2: Industry Development - The projects signed will enhance the local innovation ecosystem and address pain points in the research and commercialization of innovative medical devices, thereby improving regional competitiveness [6][9] - Chengdu High-tech Zone has established a full industry chain system covering drug discovery, preclinical research, clinical trials, pilot testing, large-scale production, and market application, supported by national platforms and leading enterprises [10] Group 3: Future Plans - Chengdu High-tech Zone aims to continue optimizing the business environment and integrating global resources to accelerate the gathering of top talent, capital, and technology for biopharmaceutical development [10] - The "Wutong Plan" launched in May 2023 outlines a comprehensive service list for the biopharmaceutical industry, covering 47 service directions and 99 detailed services to facilitate the entire lifecycle of enterprises [9][10]